Multipotent Adult Stem Cell Isolation and Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell therapies face challenges in sourcing sufficient, immunocompatible cells for transplantation, particularly due to the limited differentiation potential of adult stem cells and the ethical concerns surrounding embryonic stem cells, which often require immunosuppression and have limited ability to differentiate into various cell types.
Innovation Solution
Isolation and cultivation of multipotent adult stem cells (MASCs) that are surface antigen negative for CD44, CD45, and HLA Class I and II, expressing transcription factors like oct3/4 and capable of differentiating into multiple cell types including osteoblasts, chondrocytes, adipocytes, and hematopoietic cells, using specific markers for identification and expansion methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If embryonic stem cells are used for transplantation, then differentiation potential is improved, but immune rejection occurs requiring immunosuppression
Solution Approach 1:
The patent uses autologous stem cells (from the patient's own bone marrow) that can self-renew and differentiate into multiple cell types. The patient's own immune system recognizes these cells as self, eliminating the need for immunosuppression while maintaining high differentiation potential across multiple lineages including hematopoietic, mesenchymal, and endothelial cells.
2Object-affected harmful factors
If adult stem cells are used for transplantation, then immune compatibility is improved, but differentiation potential deteriorates
Solution Approach 1:
The patent performs ex vivo expansion and differentiation of stem cells before transplantation. Bone marrow-derived stem cells are harvested, expanded in culture with specific growth factors, and pre-differentiated into desired cell types (such as hematopoietic cells, osteoblasts, chondrocytes) before being returned to the patient, thereby enhancing differentiation potential while maintaining immune compatibility.
Solution Approach 2:
The patent alters culture conditions including growth factors, serum concentrations, and oxygen levels to induce differentiation of adult stem cells into multiple lineages. By changing physical and chemical parameters during ex vivo culture, the stem cells acquire enhanced differentiation capabilities while retaining their immunocompatible phenotype.
3Loss of time
If donor organs are obtained for transplantation, then immediate transplant availability is improved, but shortage of donors deteriorates
Solution Approach 1:
The patent enables patients to serve as their own donors by harvesting stem cells from their own bone marrow. This autologous approach eliminates the need for external donors, ensures immediate cell availability for transplantation, and provides an unlimited source of stem cells that can be expanded ex vivo to meet therapeutic demands.
Data Source
AI summary
The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.